199 related articles for article (PubMed ID: 37395975)
21. Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis.
Wiegreffe S; Sarria GR; Layer JP; Dejonckheere E; Nour Y; Schmeel FC; Anton Giordano F; Schmeel LC; Popp I; Grosu AL; Gkika E; Stefaan Dejonckheere C
Radiother Oncol; 2024 May; 197():110331. PubMed ID: 38772476
[TBL] [Abstract][Full Text] [Related]
22. Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA; De Ruysscher DKM; De Jaeger K; Koppe F; Lambrecht MLF; Lievens YN; Dieleman EMT; Jaspers JPM; Van Meerbeeck JP; Ubbels F; Kwint MH; Kuenen MA; Deprez S; De Ruiter MB; Boogerd W; Sikorska K; Van Tinteren H; Schagen SB
J Thorac Oncol; 2021 May; 16(5):840-849. PubMed ID: 33545387
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001.
Cherng HR; Sun K; Bentzen S; Armstrong TS; Gondi V; Brown PD; Mehta M; Mishra MV
Neuro Oncol; 2024 May; 26(5):911-921. PubMed ID: 38069666
[TBL] [Abstract][Full Text] [Related]
24. Cranial radiation therapy with hippocampus avoidance in lung cancer treatment: systematic review and meta-analysis.
Zheng Y; You L; Feng B; Tang M; Na F
Front Oncol; 2023; 13():1268754. PubMed ID: 37936606
[TBL] [Abstract][Full Text] [Related]
25. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
[TBL] [Abstract][Full Text] [Related]
26. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
27. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
[TBL] [Abstract][Full Text] [Related]
28. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand?
Crockett C; Belderbos J; Levy A; McDonald F; Le Péchoux C; Faivre-Finn C
Lung Cancer; 2021 Dec; 162():96-105. PubMed ID: 34768007
[TBL] [Abstract][Full Text] [Related]
30. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.
Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM
Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415
[TBL] [Abstract][Full Text] [Related]
32. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.
Gondi V; Deshmukh S; Brown PD; Wefel JS; Armstrong TS; Tome WA; Gilbert MR; Konski A; Robinson CG; Bovi JA; Benzinger TLS; Roberge D; Kundapur V; Kaufman I; Shah S; Usuki KY; Baschnagel AM; Mehta MP; Kachnic LA
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):571-580. PubMed ID: 37150264
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
[TBL] [Abstract][Full Text] [Related]
34. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
Korkmaz Kirakli E; Oztekin O
Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
[TBL] [Abstract][Full Text] [Related]
35. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
36. Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study.
Pospisil P; Kazda T; Hynkova L; Bulik M; Dobiaskova M; Burkon P; Laack NN; Slampa P; Jancalek R
Radiother Oncol; 2017 Mar; 122(3):373-379. PubMed ID: 28063694
[TBL] [Abstract][Full Text] [Related]
37. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
[TBL] [Abstract][Full Text] [Related]
38. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
39. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
[TBL] [Abstract][Full Text] [Related]
40. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
